Marvel Biosciences Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$2,291,389 over the previous period. Total operating expenses were $2,318,933.
Profit Margin
| 2019 | 0 | -98.04K | |
|---|---|---|---|
| 2020 | 0 | -955.65K | |
| 2021 | 0 | -3.03M | |
| 2022 | 0 | -2.55M | |
| 2023 | 0 | -2.29M |
MRVL.V Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 887.51K | 1.37M | 613.09K | 265.2K | 0 |
Gross profit | -887.51K | -1.37M | -613.09K | -265.2K | 0 |
Operating exp. | |||||
Research and development | 887.51K | 1.37M | 613.09K | 265.2K | 0 |
Selling and marketing | 312.45K | 0 | 0 | 0 | 0 |
Total operating expenses | 2.31M | 1.17M | 485.04K | 689.57K | 100.04K |
Operating income | -2.31M | -2.54M | 806.33K | -954.20K | -100.05K |
Other income (expenses), net | 27.54K | -4.31K | -1.93M | 63.35K | 2.00K |
Income before tax | -2.29M | -2.55M | -3.03M | -955.65K | -98.04K |
Income tax expense | 0 | 5.86K | 1.90M | 886 | 0 |
Net income | -2.29M | -2.55M | -3.03M | -955.65K | -98.04K |
Earnings per share | |||||
Basic EPS | -0.05 | -0.07 | -0.17 | -0.13 | -0.03 |
Diluted EPS | -0.05 | -0.07 | -0.17 | -0.13 | -0.03 |